Position in COGT
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$8,034,468
+$1,288,095 QoQ
Shares Held
207,609
+18.4% QoQ
Ownership
0.120%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#104
of 321 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 23%
Shared 0%
None 77%
Common Shares in COGT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RHUMBLINE ADVISERS holds $1,404,724,682 across 329 Biotechnology names. COGT ranks #33 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
396,380 | $196,893,837 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,794 | $98,390,870 | |
| 3 | MRNA |
Moderna, Inc.
|
809,853 | $56,714,005 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
165,579 | $49,844,246 | |
| 5 | INCY |
Incyte Corp
|
428,533 | $48,578,500 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
226,008 | $42,326,778 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
1,178,789 | $41,717,342 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
163,018 | $39,282,447 |
All Filings in COGT
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,034,468 | 207,609 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $6,746,373 | 175,276 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $6,399,851 | 180,176 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,537,584 | 176,712 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $1,123,792 | 156,517 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $781,443 | 130,458 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $979,531 | 125,581 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $1,349,146 | 124,921 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,100,249 | 130,516 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $800,573 | 119,133 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $681,791 | 115,951 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $1,109,881 | 113,834 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $1,185,835 | 100,155 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $1,008,444 | 93,461 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $1,071,981 | 92,732 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,324,284 | 88,759 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $573,536 | 63,585 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $306,430 | 40,912 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $333,375 | 38,855 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $332,993 | 39,595 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $310,450 | 38,280 | Shares | Sole | 2021-08-05 | |
| No filing history on record for this holder in this stock. | ||||||